hsa-mir-6846-5p _LIHC.png
CALR _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018509
Fusion event
HBV-CALR integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
480
End
639
Integrated sequence
CTAATTCCAGGATCCTCAACAACCAGCACGGGACCATGCCGGACCTGCATGACTACTGCTCAAGGAACCTCTATGTATCCCTCCTGTTGCTGTACCAAACCTTCGGACGGAAATTGCACCTGTATTCCCATCCCATCATCCTGGGCTTTCGGAAAATTCC
Host Sequence
Chromosome
chr19
Cytoband
p13.13
Reference genome
End
13054443/12943629 (Hg38)
Location type
Exon8
Fragile sites / regions
Target gene
miRNAs that regulate target gene
hsa-mir-124-3p ; hsa-mir-122-5p ; hsa-mir-1-3p ; hsa-mir-16-5p ; hsa-mir-423-3p ; hsa-mir-320a ; hsa-mir-149-5p ; hsa-mir-148a-5p ; hsa-mir-516a-5p ; hsa-mir-875-3p ; hsa-mir-1254 ; hsa-mir-3116 ; hsa-mir-3148 ; hsa-mir-3646 ; hsa-mir-3662 ; hsa-mir-6849-3p ; hsa-mir-6782-5p ; hsa-mir-412-3p ; hsa-mir-6783-3p ; hsa-mir-1343-3p ; hsa-mir-6848-5p ; hsa-mir-6846-5p ; hsa-mir-4697-5p ; hsa-mir-4488 ; hsa-mir-1237-5p ; hsa-mir-486-3p ; hsa-mir-6721-5p ; hsa-mir-6878-5p ; hsa-mir-4763-3p ; hsa-mir-1207-5p ; hsa-mir-6722-3p ; hsa-mir-1909-3p ; hsa-mir-6738-5p ; hsa-mir-5194 ; hsa-mir-1914-3p ; hsa-mir-1225-3p ; hsa-mir-1253 ; hsa-mir-3179 ; hsa-mir-203a-3p ; hsa-mir-5681a ; hsa-mir-6742-3p ; hsa-mir-637 ; hsa-mir-6852-5p ; hsa-mir-939-3p ; hsa-mir-1910-5p ; hsa-mir-6838-3p ; hsa-mir-4756-5p ; hsa-mir-4739 ; hsa-mir-1321 ; hsa-mir-5197-3p ; hsa-mir-1252-3p ; hsa-mir-4533 ; hsa-mir-4518 ; hsa-mir-4468 ; hsa-mir-1266-5p ; hsa-mir-3664-3p ; hsa-mir-1245b-3p ; hsa-mir-6876-5p ; hsa-mir-4476 ; hsa-mir-2278 ; hsa-mir-4428 ; hsa-mir-665 ; hsa-mir-216a-5p ; hsa-mir-4534 ; hsa-mir-4665-5p ; hsa-mir-1275 ; hsa-mir-4472 ; hsa-mir-7847-3p ; hsa-mir-4447 ; hsa-mir-92a-2-5p ; hsa-mir-6766-5p ; hsa-mir-6756-5p ; hsa-mir-608 ; hsa-mir-4651 ; hsa-mir-7110-5p ; hsa-mir-6842-5p ; hsa-mir-6752-5p ; hsa-mir-5010-5p ; hsa-mir-4525 ; hsa-mir-6870-5p ; hsa-mir-7111-5p ; hsa-mir-5698 ; hsa-mir-4723-5p ; hsa-mir-625-5p ; hsa-mir-6825-5p ; hsa-mir-3175 ; hsa-mir-6883-5p ; hsa-mir-6785-5p ; hsa-mir-4728-5p ; hsa-mir-149-3p ; hsa-mir-8085 ; hsa-mir-6787-5p ; hsa-mir-6731-5p ; hsa-mir-663a ; hsa-mir-1908-5p ; hsa-mir-6894-5p ; hsa-mir-765 ; hsa-mir-7154-3p ; hsa-mir-766-5p ; hsa-mir-5192 ; hsa-mir-4749-5p ; hsa-mir-4706 ; hsa-mir-4693-3p ; hsa-mir-6889-5p ; hsa-mir-6777-5p ; hsa-mir-6732-5p ; hsa-mir-6783-5p ; hsa-mir-4779 ; hsa-mir-3141 ; hsa-mir-6124 ; hsa-mir-342-3p ; hsa-mir-6716-3p ; hsa-mir-6771-3p
Nearest miRNA
hsa-mir-10395/Upstream/2993; hsa-let-7e/Downstream/892658;
Upstream sequence
CAAAGAAGCATTTGTGGAGCACCTTCTGTGTGCCCCTAGGTACTAGATGCCTGGACGGGGTCAGAAGGACCCTGACCCACCTTGAACTTGTTCCACACAG
Downstream sequence
GTGAGGCCTGGTCCTGGTCCTGATGTCGGGGGCGGGCAGGGCTGGCAGGGGGCAAGGCCCTGAGGTGTGTGCTCTGCCTGCAGGCAGCAGAGAAACAAAT
Target sequence
CAGGTCAAGTCTGGCACCATCTTTGACAACTTCCTCATCACCAACGATGAGGCATACGCTGAGGAGTTTGGCAACGAGACGTGGGGCGTAACAAAG
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Curate